Next Article in Journal
Evaluation of Different Strategies to Improve the Management of Helicobacter pylori Infection at the Primary Care Level: Training Sessions Increase Prescription Appropriateness of Treatment Regimens
Next Article in Special Issue
Association between Carbapenem Consumption and Clinical Outcomes in an In-Hospital Setting: Analysis of a Japanese Nationwide Administrative Database in 2020
Previous Article in Journal
Development and Psychometric Evaluation of the Antibiotic Knowledge and Consumption Tool (AKCT)
Previous Article in Special Issue
Implementation of Clinical Practice Guidelines for Empirical Antibiotic Therapy of Bacteremia, Urinary Tract Infection, and Pneumonia: A Multi-Center Quasi-Experimental Study
 
 
Article
Peer-Review Record

Days of Antibiotic Spectrum Coverage Trends and Assessment in Patients with Bloodstream Infections: A Japanese University Hospital Pilot Study

Antibiotics 2022, 11(12), 1745; https://doi.org/10.3390/antibiotics11121745
by Masayuki Maeda 1,*, Mari Nakata 2, Yuika Naito 2, Kozue Yamaguchi 1, Kaho Yamada 1, Ryoko Kinase 1, Takahiro Takuma 3, Rintaro On 3 and Issei Tokimatsu 3
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Antibiotics 2022, 11(12), 1745; https://doi.org/10.3390/antibiotics11121745
Submission received: 9 November 2022 / Revised: 30 November 2022 / Accepted: 1 December 2022 / Published: 2 December 2022

Round 1

Reviewer 1 Report

This study indicated the relationship DASC, DOT, DASC/DOT metrics for evaluation as benchmark for over- or miss-use of antimicrobials for patients of blood stream infection.  This pilot study is limited data but novel and interesting work.

 

 1. Lines 134-136: The results indicated great relationship between DASC and DOT. Therefore, metrics of the evaluation may be sufficient in DASC and DASC/DOT or DOT and DASC/DOT. Please indicate why three metrics (DASC, DOT, DASC/DOT) are needed.

 

2. Limitation section: As the concept of DASC is not yet widespread, it is recommended that the limitations with regard to DASC are also briefly described with reference to [19] etc.

Author Response

Reviewer #1:

Thank you very much for reviewing our manuscript together with the comments. The suggestions for improving the manuscript were very helpful in preparing a revised submission. We revised the manuscript according to your suggestions.

 

  1. Lines 134-136: The results indicated great relationship between DASC and DOT. Therefore, metrics of the evaluation may be sufficient in DASC and DASC/DOT or DOT and DASC/DOT. Please indicate why three metrics (DASC, DOT, DASC/DOT) are needed.

Response:

Thank you for the comment. As the reviewer's pointing out, a strong correlation was observed between DASC and DOT. We agree with the reviewer's comment that it is sufficient to evaluate the metrics using only DASC and DASC/DOT. We revised that sentence.

Change(s): P6 L136

 

  1. Limitation section: As the concept of DASC is not yet widespread, it is recommended that the limitations with regard to DASC are also briefly described with reference to [19] etc.

Response:

Thank you for the comment. We referred to the previous DASC study. Since this metric has just been developed, it is not widespread in the U.S. as well as in Japan where the DOTs are widely collected using an electronic surveillance system. We believe that it will be necessary to develop an electronic database for DASC collection. We have added this insight to the limitation section.

Change(s): P7 L178-180

Finally, the concept of DASC has not been widespread in Japan. The development of an electronic surveillance system would be needed to aggregate the DASC data in each hospital.

Author Response File: Author Response.pdf

Reviewer 2 Report

This research article suggests new metrics to evaluate the antibiotic spectrum for bloodstream infection patients. The researchers suggest DASC and DOT would be useful tools for evaluating appropriate antibiotic use in BSIs.

1. Ref: It contains some inappropriate references. Some unnecessary references should be deleted. For example, I'm not sure why ref #1 is included in the reference list.

2. It would be nice to rearrange figures 5, 6, and 7. If the numbers are arranged in ascending order, it seems to be easier to interpret the data intuitively.

I felt that the manuscript story was not well organized overall. Although DASC and DOT related metrics were found to have a relationship, it is not persuasive enough that they have advantages over the previously used metrics.

Author Response

Reviewer #2:

Thank you very much for reviewing our manuscript together with the comments. The suggestions for improving the manuscript were very helpful in preparing a revised submission. We revised the manuscript according to your suggestions.

 

 

  1. Ref: It contains some inappropriate references. Some unnecessary references should be deleted. For example, I'm not sure why ref #1 is included in the reference list.

Response:

According to the reviewer's comment, we revised the reference list. Reference No. 1, 20, and 30 were deleted.

Change(s): Please refer each reference number and reference list in the manuscript.

 

  1. It would be nice to rearrange figures 5, 6, and 7. If the numbers are arranged in ascending order, it seems to be easier to interpret the data intuitively.

Response:

According to the reviewer’s comment, we arranged them in ascending order.

Change(s): We replaced the Fig. 5, 6, and 7 (Page 4-5).

 

  1. I felt that the manuscript story was not well organized overall. Although DASC and DOT related metrics were found to have a relationship, it is not persuasive enough that they have advantages over the previously used metrics.

Response:

Thank you for the comment. We could not evaluate DASC utility in actual activities compared with conventional metrics. However, the previous study indicated the utility and advantage of DASC compared with other metrics. We have added this insight to the limitation section.

Change(s): P6-7 L174-177

The previous study suggested that the efforts of ASPs to use narrower-spectrum antibiotics through empiric therapy or de-escalation are not evaluated in the DOT-based metrics.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Thank you for taking my suggestion into account and for making the corrections. I have no further comments.

Back to TopTop